Deciphera Pharmaceuticals Inc (DCPH)
25.45
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
25.46
+0.01
(+0.04%)
After-Hours: 20:00
Deciphera Pharmaceuticals Cash from Investing (Quarterly): 62.63M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 62.63M |
| December 31, 2023 | 2.199M |
| September 30, 2023 | 41.40M |
| June 30, 2023 | 4.361M |
| March 31, 2023 | -35.41M |
| December 31, 2022 | 16.30M |
| September 30, 2022 | -6.071M |
| June 30, 2022 | -104.19M |
| March 31, 2022 | 59.65M |
| December 31, 2021 | 98.95M |
| September 30, 2021 | 14.44M |
| June 30, 2021 | -60.45M |
| March 31, 2021 | 123.91M |
| December 31, 2020 | 46.08M |
| September 30, 2020 | 1.821M |
| Date | Value |
|---|---|
| June 30, 2020 | -17.75M |
| March 31, 2020 | -1.69M |
| December 31, 2019 | 1.68M |
| September 30, 2019 | -294.81M |
| June 30, 2019 | 12.26M |
| March 31, 2019 | -179.65M |
| December 31, 2018 | -0.303M |
| September 30, 2018 | -0.216M |
| June 30, 2018 | -1.524M |
| March 31, 2018 | -0.151M |
| December 31, 2017 | -0.13M |
| September 30, 2017 | -0.202M |
| June 30, 2017 | -0.04M |
| March 31, 2017 | -0.034M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-294.81M
Minimum
Sep 2019
123.91M
Maximum
Mar 2021
-1.735M
Average
3.28M
Median
Cash from Investing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -19.62B |
| Dynavax Technologies Corp | 2.831M |
| Gilead Sciences Inc | -2.207B |
| Esperion Therapeutics Inc | -0.073M |
| SINTX Technologies Inc | -0.062M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -54.58M |
| Cash from Financing (Quarterly) | 0.522M |
| Free Cash Flow | -152.39M |
| Free Cash Flow Per Share (Quarterly) | -0.6263 |
| Free Cash Flow to Equity (Quarterly) | -54.73M |
| Free Cash Flow Yield | -6.94% |